Where U.S. Regulatory Precision Meets India’s Clinical Scale
We help global sponsors cut 6–9 months from trial startup by combining U.S.-grade governance with India’s Tier-1 oncology and multispecialty networks. Our strategy-first model delivers predictable approvals, transparent execution, and audit-ready operations — without the offshore friction CROs struggle with.
Tailored Services for You
Built around your program needs, our services unite U.S. governance, India delivery, and real-time analytics—ensuring faster, cleaner, and predictable clinical execution.
01
Regulatory Approvals
- 4-5 weeks
- 98% Success Rate (150+ clearances)
- Manufacturing licenses 6-8 weeks
02
Nationwide Research Network
- 450+ professionals
- 240+ sites
- 180+ investigators
- 100% Inspection Pass Rate
03
45-65% Cost Savings + 4-6X ROI Guarantee
- $1.4M-$2.4M savings
- 4-6X ROI
- Flexible billing options
- Zero hidden costs
Your Strategic Clinical Research Partner for High-Performance Trials in India
eteraflex connects is a US-based clinical research Company specializing in exceptional operational excellence for small and mid-cap biotechnology companies and medical device manufacturers conducting trials in India. As a leading contract research organization, we deliver comprehensive CRO services through our proven integrated delivery model, combining 18 years of focused market experience with established regulatory relationships.
Our Core Offerings
Our unique value proposition bridges American business standards with India’s operational excellence, eliminating traditional offshore coordination challenges while delivering measurable outcomes:
Our Technologies
Our proprietary platforms, ClintrialX and HeliX, enable predictive risk management, automated compliance, and cost optimization.
Technical Clinical Consulting
- Accelerate Regulatory Approvals
- Enhance Data Management and Integrity
- Improve Patient Engagement and Retention
- Streamline Site Selection and Management
Why Choose Us ?
Our unique value proposition bridges global business standards with India’s operational excellence, eliminating traditional offshore coordination challenges while delivering measurable outcomes:
Competitive Cost Structure
45-65% cost reduction compared to US and European markets – Transparent pricing with performance-based fee structures – Guaranteed 4-6X ROI within 12 months for FSP programs – Complete financial predictability without hidden costs
Proven Regulatory Excellence
4-5 week approvals (vs. 12-16 week industry average) – 98% first-submission approval rate – 150+ successful regulatory clearances – Zero critical audit findings over 24 months
Our Infrastructure
450+ dedicated professionals across validated networks – 240+ active clinical research sites nationwide – 180+ experienced investigators across therapeutic areas – Dual-sector expertise serving biotechnology and medical device sectors
Strategic Differentiators
Our clinical research organization delivers measurable competitive advantages through
Cultural Integration:
US-based leadership with India operational teams
Regulatory Relationships:
Established CDSCO connections and submission expertise
Quality Assurance:
100% inspection pass rate across completed programs
Operational Scale:
Enterprise-level infrastructure with personalized attention
lorem impusumlorem impusumlorem impusumlorem impusumlorem impusumlorem impusumlorem impusumlorem impusumlorem impusumlorem impusumlorem impusum
End-to-end clinical research across all phases. 240+ sites, 100% inspection pass rate.